BSE filing, NSE: BAIDFIN. Summary written from the filing by ALFA Finder's alert engine.
Baid Finserv Ltd: key numbers
- Share price
- ₹9.71
- Market cap
- ₹150.4 Cr
- Revenue (annual)
- ₹97.27 Cr
- Net profit (annual)
- ₹14.97 Cr
- P/E (TTM)
- 9.8×Sector 19.7×
- Promoter holding
- 49.73%+2.34% QoQ
- FII holding
- 0.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Baid Finserv Ltd
All →Baid Finserv Management Change
Mr. Anurag Patni ceased as Independent Director of Baid Finserv upon completing his second and final five-year term. The departure is effective from 21 October 2026.
Baid Finserv Other Announcement
Baid Finserv reported zero re-lodgement requests for physical shares for September 2026 under a SEBI special window. A routine RTA compliance statement with no transaction or business impact.
Baid Finserv Credit Rating
CARE Ratings re-affirmed Baid Finserv Limited's credit rating at CARE BBB; Stable / CARE A3. The rating applies to bank facilities totaling Rs. 305.00 Crore.
- Value
- ₹305.0 Cr
Baid Finserv Management Change
Baid Finserv Limited reported the re-appointment of Mr. Panna Lal Baid as Chairman and Managing Director for three years, approved at the recent AGM.
Baid Finserv Annual General Meeting
Baid Finserv Limited conducted its 35th Annual General Meeting on September 23, 2026. Shareholders approved the financial statements, dividend declaration, and key director appointments.
Baid Finserv Capital Structure Change
Baid Finserv Limited received consideration for the preferential issue of 1.20 Crore warrants. This auditor's certificate confirms receipt of Rs.18.13 Crore for the issue.
- Value
- ₹18.13 Cr
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.